Ticker LaunchRegulation A · Tier 2 · BDPT
Bioadaptives, Inc.
Bioadaptives, Inc. (BDPT) filed a Tier 2 Regulation A offering statement (Form 1-A) on Mar 4, 2022 for up to $1.5M at $0.0075 per security. The SEC qualified the offering on May 11, 2022.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $1.5M
- Offer price
- $0.0075
- Security type
- Equity (common or preferred stock)
- Filed
- Mar 4, 2022
- Qualified
- May 11, 2022
- Ticker
- BDPT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- State
- NV
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Mar 4, 2022
- Exit report (Form 1-Z)
- All filings on EDGAR CIK 1575142
Other qualified Biotech & pharma Reg A offerings
- Puraverde Inc.Aug 11, 2022 · $50M
- Oncolyze, Inc.Aug 4, 2022 · $15.3M
- Kurve Therapeutics, Inc.Aug 3, 2022 · $50M
- Aeris Biotechnologies, Inc.Jul 26, 2022 · $15M
- BioLIfe Sciences IncJun 30, 2022 · $20M
- Balanced Pharma IncApr 8, 2022 · $25M